Találati lista | Tudóstér

001-es BibID:	BIBFORM104496
035-os BibID:	(scopus)85132856048 (wos)000816988100001
Első szerző:	Blennow, Ola
Cím:	Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies : an EPICOVIDEHA survey report / Blennow Ola, Salmanton-García Jon, Nowak Piotr, Itri Federico, Van Doesum Jaap, López-García Alberto, Farina Francesca, Jaksic Ozren, Pinczés László Imre, Bilgin Yavuz M., Falces-Romero Iker, Jiménez Moraima, Ormazabal-Vélez Irati, Weinbergerová Barbora, Duléry Rémy, Stojanoski Zlate, Lahmer Tobias, Fernández Noemí, Hernández-Rivas José-Ángel, Petzer Verena, De Jonge Nick, Glenthj Andreas, De Ramón Cristina, Biernat Monika M., Fracchiolla Nicola, Aujayeb Avinash, Van Praet Jens, Schönlein Martin, Méndez Gustavo-Adolfo, Cattaneo Chiara, Guidetti Anna, Sciume Mariarita, Ammatuna Emanuele, Cordoba Raul, García-Poutón Nicole, Gräfe Stefanie, Cabirta Alba, Wolf Dominik, Nordlander Anna, García-Sanz Ramón, Delia Mario, Berg Venemyr Caroline, Brones Clara, Di Blasi Roberta, De Kort Elizabeth, Meers Stef, Lamure Sylvain, Serrano Laura, Merelli Maria, Coppola Nicola, Bergantim Rui, Besson Caroline, Kohn Milena, Petiti Jessica, Garcia-Vidal Carolina, Dargenio Michelina, Danion Francois, Machado Marina, Bailén-Almorox Rebeca, Hoenigl Martin, Dragonetti Giulia, Chai Louis Yi Ann, Kho Chi Shan, Bonanni Matteo, Liévin Raphaël, Marchesi Francesco, Cornely Oliver A., Pagano Livio
Dátum:	2022
ISSN:	0361-8609 1096-8652
Tárgyszavak:	Orvostudományok Klinikai orvostudományok levél folyóiratcikk
Megjelenés:	American Journal of Hematology. - 97 : 8 (2022), p. E312-E317. -
További szerzők:	Salmanton-García, Jon Nowak, Piotr Itri, Federico van Doesum, Jaap López-García, Alberto Farina, Francesca Jaksic, Ozren Pinczés László Imre (1990-) (általános orvos) Bilgin, Yavuz M. Falces-Romero, Iker Jiménez, Moraima Ormazabal-Vélez, Irati Weinbergerová, Barbora Duléry, Rémy Stojanoski, Zlate Lahmer, Tobias Fernández, Noemí Hernández-Rivas, José-Ángel Petzer, Verena de Jonge, Nick Glenthj, Andreas De Ramón, Cristina Biernat, Monika M. Fracchiolla, Nicola S. Aujayeb, Avinash van Praet, Jens Schönlein, Martin Méndez, Gustavo-Adolfo Cattaneo, Chiara Guidetti, Anna Sciumè, Mariarita Ammatuna, Emanuele Cordoba, Raul García-Poutón, Nicole Gräfe, Stefanie Cabirta, Alba Wolf, Dominik Nordlander, Anna García-Sanz, Ramón Delia, Mario Berg Venemyr, Caroline Brones, Clara Di Blasi, Roberta De Kort, Elizabeth Meers, Stef Lamure, Sylvain Serrano, Laura Merelli, Maria Coppola, Nicola Bergantim, Rui Besson, Caroline Kohn, Milena Petiti, Jessica Garcia-Vidal, Carolina Dargenio, Michelina Danion, Francois Machado, Marina Bailén-Almorox, Rebeca Hoenigl, Martin Dragonetti, Giulia Chai, Louis Yi Ann Kho, Chi Shan Bonanni, Matteo Liévin, Raphaël Marchesi, Francesco Cornely, Oliver Andreas Pagano, Livio
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM099465
Első szerző:	Jóna Ádám (orvos)
Cím:	Pulmonary Toxicity of Hodgkin Lymphoma Treatment : a Prospective Single-Center Study / Jona Adam, Miltenyi Zsofia, Pinczes Laszlo, Kerek Patricia, Bittner Nora, Szilasi Maria, Barna Sandor, Illes Arpad
Dátum:	2021
ISSN:	1927-1212 1927-1220
Megjegyzések:	Background: Standard bleomycin-containing first-line therapy and/or irradiation may cause pulmonary toxicity in Hodgkin lymphoma (HL) patients. Our aim was to prospectively assess effects of chest irradiation, bleomycin administration, and other factors on lung function in the treatment of patients with HL.Methods: Pulmonary function of newly diagnosed HL patients was assessed via a St. George Respiratory Questionnaire, dynamic inhalation lung scintigraphy, spirometry, and an assessment of the diffusion capacity of the lung for carbon monoxide (DLCO) before, during, and after treatment.Results: This prospective study was conducted at the University of Debrecen. The study included 84 patients with classical HL. Most patients received standard doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy. Both intramuscular and intravenous administrations of bleomycin were used. Brentuximab vedotin combination chemotherapy was administered to 12 patients. Mediastinal involved-field irradiation therapy (IFRT) was used to treat 16 patients. Lung scintigraphy revealed pulmonary toxicity more sensitively than DLCO. Intravenous bleomycin administration decreased diethylenetriamine pentaacetic acid clearance. Intramuscular bleomycin had the lowest level of pulmonary toxicity among considered treatments. Currently used, mediastinal IFRT had a lower level of pulmonary toxicity than bleomycin. The current prospec-tive evaluation confirmed previous results that determined that cumulative bleomycin dose and administration are major risk factors for pulmonary toxicity, while the currently used treatment method, mediastinal irradiation, was determined to be relatively safe for treating for HL patients.Conclusion: We agree with decreasing bleomycin dosage and number of cycles administered and we do not recommend avoiding mediastinal IFRT, unless multiple pulmonary risk factors are present.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk Hodgkin lymphoma Pulmonary toxicity Bleomycin Irradiation Brentuximab vedotin Scintigraphy Pulmonary fibrosis Combination therapy
Megjelenés:	Journal of Hematology. - 10 : 6 (2021), p. 266-273. -
További szerzők:	Miltényi Zsófia (1975-) (belgyógyász, haematológus) Pinczés László Imre (1990-) (általános orvos) Kerek Patrícia (1996-) (Orvos) Bittner Nóra (1963-) (orvos) Szilasi Mária (1953-) (tüdőgyógyász, klinikai immunológus, allergológus, belgyógyász) Barna Sándor (1982-) (kutató orvos) Illés Árpád (1959-) (belgyógyász, haematológus, onkológus)
Pályázati támogatás:	UNKP-20-4 Egyéb
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM080564
035-os BibID:	(PMID)31228077
Első szerző:	Nyilas Renáta
Cím:	Interim PET/CT in diffuse large B-cell lymphoma may facilitate identification of good-prognosis patients among IPI-stratified patients / Renata Nyilas, Bence Farkas, Reka Rahel Bicsko, Ferenc Magyari, Laszlo Imre Pinczes, Arpad Illes, Lajos Gergely
Dátum:	2019
ISSN:	0925-5710 1865-3774
Megjegyzések:	Treating patients with DLBCL remains a challenge, as the response to first-line immunochemotherapy is somewhat unpredictable. The International Prognostic Index (IPI) is one of the most widely used methods for assessing prognosis. Interim PET/CT (iPET/CT) can play an important role in the early identification of 'non-responder' patients before the end of treatment examination. In this study, we retrospectively analyzed 104 newly diagnosed DLBCL patients treated with R-CHOP-like regimens who underwent iPET/CT imaging during therapy. There was a significant difference in 2-year OS between patients with negative iPET/CT and those with positive iPET/CT. Patients who had positive iPET/CT showed inferior 2-year PFS compared to those with negative iPET/CT. According to IPI, there was a statistically significant difference in 2-year OS and PFS between patients in the lower and higher risk groups. However, these patients can be further subdivided according to iPET/CT. The iPET/CT results in the present study clearly separate good- and poor-prognosis patients according to differences in 2-year OS, both in the lower and higher IPI risk groups. These results are in agreement with those of previous studies that demonstrated that iPET/CT has high negative predictive value, clearly identifying good-prognosis patients even within the poor-prognosis IPI group.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk DLBCL Diffuse large B-cell lymphoma Interim PET/CT PET/CT Response
Megjelenés:	International Journal of Hematology. - 110 : 3 (2019), p. 331-339. -
További szerzők:	Farkas Bence Bicskó Réka Ráhel (1994-) (általános orvos) Magyari Ferenc (1985-) (belgyógyász, hematológus) Pinczés László Imre (1990-) (általános orvos) Illés Árpád (1959-) (belgyógyász, haematológus, onkológus) Gergely Lajos (1965-) (belgyógyász, haematológus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM094247
Első szerző:	Pinczés László Imre (általános orvos)
Cím:	The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma / Pinczés László Imre, Szabó Roxána, Miltényi Zsófia, Illés Árpád
Dátum:	2021
ISSN:	0925-5710 1865-3774
Megjegyzések:	The characteristics of autoimmune cytopenias (AICP) associated with Hodgkin lymphoma (HL) are not thoroughly defined. We retrospectively assessed the clinical features of HL-associated AICPs in 563 HL patients diagnosed over a period of 28 years. We identified 8 cases of autoimmune hemolytic anemia (AIHA) and 8 cases of autoimmune thrombocytopenia among 14 patients altogether. Four (26%) AICPs were present at lymphoma diagnosis, while 11 (74%) cytopenias occurred during follow-up after first-line therapy. The overall incidence of HL-associated AICPs was 2.8%. Nine (75%) cytopenias responded to intravenous steroids. Seven (46%) AICPs led to the diagnosis of HL, indicated a relapse, or revealed secondary malignancies. AIHAs and AICPs altogether were more likely to develop in patients with advanced-stage HL (p = 0.010 and p < 0.004, respectively). HL patients experiencing AICPs had an increased short-term (1-year) mortality compared to the general HL population (p < 0.022). The 5-year OS of HL patients with concurrent AICPs at diagnosis was inferior compared to HL patients developing AICPs during follow-up (p = 0.005), and to HL patients without AICPs (p < 0.001). Patients with HL-associated AICPs appear to have a particular disease-related profile. The association of HL and AICPs may increase short-term mortality, while patients with concurrent AICPs at HL diagnosis have a dismal prognosis.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk Autoimmune hemolytic anemia Autoimmune thrombocytopenia Evans syndrome Hodgkin lymphoma Overall survival
Megjelenés:	International Journal Of Hematology. - 113 : 2 (2021), p. 175-182. -
További szerzők:	Szabó Roxána Miltényi Zsófia (1975-) (belgyógyász, haematológus) Illés Árpád (1959-) (belgyógyász, haematológus, onkológus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: